AVGO vs DHR: Which Is the Better Buy?
Side-by-side comparison of Broadcom Inc. and Danaher Corporation — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-07-10.
Broadcom Inc. · Technology
$379.86
-41.0% upside to fair value
Grade C
High Quality
VS
Danaher Corporation · Healthcare
$195.98
+7.9% upside to fair value
Grade B
High Quality
QuantHub Verdict
DHR has more upside to fair value
(+7.9%).
DHR trades at a lower forward P/E
(37.8x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
AVGO |
DHR |
| Current Price |
$379.86 |
$195.98 |
| Fair Value Estimate |
$223.93 |
$211.54 |
| Upside to Fair Value |
-41.0%
|
+7.9%
|
| Market Cap |
$1,806.8B |
$138.7B |
| Forward P/E |
61.3x
|
37.8x
|
| EV / EBITDA |
44.1x
|
22.8x
|
| Price / Sales |
23.9x
|
5.6x
|
| Price / FCF |
55.2x
|
26.2x
|
| Revenue Growth YoY |
+47.9%
|
+3.7%
|
| Gross Margin |
67.0%
|
60.7%
|
| Operating Margin |
43.7%
|
21.0%
|
| Return on Equity |
36.4%
|
7.1%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
1.81%
|
3.81%
|
| Analyst Consensus |
Strong Buy
|
Strong Buy
|
Investment Thesis
Broadcom Inc. is a leading technology company specializing in semiconductors and infrastructure software, with a business split nearly evenly between these two segments. The company benefits from a durable competitive moat driven by customer concentration in mission-critical infrastructure, high switching costs, and a broad portfolio spanning semiconductors and infrastructure software. Broadcom h…
Danaher Corporation operates in the healthcare sector, specifically in medical diagnostics and research, delivering high-quality products with a durable competitive moat supported by strong margins and consistent earnings growth. The company trades at a trailing and forward P/E of 37.76, which is relatively high but justified by its stable revenue growth of 3.7% and earnings growth of 7.9% in the…
Accumulation Zones
| Metric |
AVGO |
DHR |
| Zone Low |
$167.95 |
$158.66 |
| Zone High |
$190.34 |
$179.81 |
| In Buy Zone? |
No
|
No
|